Literature DB >> 30051623

A randomized controlled trial of the compuLsive Exercise Activity TheraPy (LEAP): A new approach to compulsive exercise in anorexia nervosa.

Phillipa Hay1, Stephen Touyz2, Jon Arcelus3,4, Kathleen Pike5, Evelyn Attia6, Ross D Crosby7, Sloane Madden8, Jackie Wales4, Michelle La Puma9, Andreea I Heriseanu2, Sarah Young8, Caroline Meyer10,11.   

Abstract

OBJECTIVE: To compare the efficacy of the compuLsive Exercise Activity theraPy (LEAP) programme integrated with manualized cognitive behavioral therapy for anorexia nervosa (CBT-AN) compared to CBT-AN alone.
METHOD: Seventy-eight adults were randomized to CBT-AN, delivered with or without eight embedded sessions of LEAP, for a total of 34 individual outpatient sessions. Participants were assessed at baseline, the end of the first phase of CBT-AN (which included LEAP), mid-therapy, end of therapy, and at 3 and 6 months follow-up. Linear mixed effects modelling was used for comparing trajectories over time by group in primary outcomes of pathological exercise cognitions and secondary outcomes of exercise frequency, BMI, eating disorder (ED) symptoms, AN stage of change, anxiety/depression, and health related quality of life.
RESULTS: There were significant improvements over time in all outcomes. There were no significant differences between treatment groups in primary outcome measures. Fidelity and end-of-treatment participant satisfaction were satisfactory across both conditions. DISCUSSION: CBT-AN and LEAP added to CBT-AN resulted in improved attitudes and beliefs toward exercise and general improvements in BMI and ED psychopathology in people with AN.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  anorexia nervosa; cognitive-behavioral; double-blinded; driven exercise; psychotherapy; therapy

Mesh:

Year:  2018        PMID: 30051623     DOI: 10.1002/eat.22920

Source DB:  PubMed          Journal:  Int J Eat Disord        ISSN: 0276-3478            Impact factor:   4.861


  7 in total

Review 1.  Psychosocial etiology of maladaptive exercise and its role in eating disorders: A systematic review.

Authors:  Sasha Gorrell; Rachael E Flatt; Cynthia M Bulik; Daniel Le Grange
Journal:  Int J Eat Disord       Date:  2021-05-04       Impact factor: 5.791

2.  The Freiburg sport therapy program for eating disorders: a randomized controlled trial.

Authors:  Almut Zeeck; Sabine Schlegel; Friederike Jagau; Claas Lahmann; Armin Hartmann
Journal:  J Eat Disord       Date:  2020-07-07

3.  Accuracy of self-reported physical activity in patients with anorexia nervosa: links with clinical features.

Authors:  Louise Bezzina; Stephen Touyz; Sarah Young; Nasim Foroughi; Stacy Clemes; Caroline Meyer; Jon Arcelus; Sloane Madden; Evelyn Attia; Kathleen M Pike; Phillipa Hay
Journal:  J Eat Disord       Date:  2019-08-23

4.  Treatment of compulsive exercise in eating disorders and muscle dysmorphia: protocol for a systematic review.

Authors:  Jordan Andre Martenstyn; Stephen Touyz; Sarah Maguire
Journal:  J Eat Disord       Date:  2021-02-10

Review 5.  A systematic review of sociodemographic reporting and representation in eating disorder psychotherapy treatment trials in the United States.

Authors:  C Blair Burnette; Jessica L Luzier; Chantel M Weisenmuller; Rachel L Boutté
Journal:  Int J Eat Disord       Date:  2022-03-14       Impact factor: 5.791

6.  An evaluation of efficacy and acceptability of a novel manualised JuniorLEAP group programme for compulsive exercise, for children and adolescents with anorexia nervosa, within an inpatient setting.

Authors:  Luisa Mang; Amie Garghan; Jessica Grant; Hubert Lacey; Rachel Matthews
Journal:  Eat Weight Disord       Date:  2020-03-30       Impact factor: 4.652

7.  Taking the LEAP: study protocol for a randomized, multicentre, naturalistic, efficacy trial of the compuLsive Exercise Activity theraPy (LEAP) - a cognitive behavioral program specifically targeting compulsive exercise in patients with eating disorders.

Authors:  Elin Monell; Caroline Meyer; Agnieszka Szwajda; Emma Forsén Mantilla
Journal:  BMC Psychiatry       Date:  2021-07-23       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.